Thursday 21 Nov, 2024 10:52 PM
Site map | Locate Us | Login
   UPL gains as Alpha Wave buys 12% in Advanta    EPFO adds 18.81 lakh net members in September    Kilburn Eng to acquire Monga Strayfield for Rs 123 cr    Natco Pharma submits ANDA with US FDA for Risdiplam    Adani Enterprises Ltd leads losers in 'A' group    Godfrey Phillips declares interim dividend of Rs 35/share    Strides Pharma jumps on securing NCLT nod for OneSource    Honasa Consumer Ltd leads losers in 'B' group    Datamatics appoints Ankush Akar as SVP & CFO    Volumes soar at Ambuja Cements Ltd counter    Honasa Consumer slumps after AICPDF flags Co's unsold inventory worth Rs 300 crore    Energy stocks edge lower    FMCG shares slide    Utilties stocks slide    BSE SME Mangal Compusolution slips on debut 
Saravan Stocks
       
Company News
Vaishali Pharma Ltd Industry:  Trading
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
535000 INE972X01022 6.1045632 VAISHALI 0 177.62 165.7 0.1 2
Date Headline
15-Nov-2024 Vaishali Pharma standalone net profit rises 15.88% in the September 2024 quarter
12-Nov-2024 Vaishali Pharma to hold board meeting
07-Nov-2024 Vaishali Pharma Ltd - Vaishali Pharma Limited - Board Meeting
17-Oct-2024 Vaishali Pharma Ltd - Vaishali Pharma Limited - Bonus
09-Oct-2024 Vaishali Pharma schedules board meeting
25-Sep-2024 Vaishali Pharma to conduct board meeting
25-Sep-2024 Vaishali Pharma Ltd - Vaishali Pharma Limited - Board Meeting
28-Aug-2024 Vaishali Pharma Ltd - Outcome of Board Meeting-XBRL
28-Aug-2024 Vaishali Pharma Ltd - Outcome of Board Meeting
28-Aug-2024 Vaishali Pharma Ltd - Bonus
1 2 3 4 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |DP Closure| |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 37011080
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd